檢索結果 - Helena Marzo‐Ortega
- Showing 1 - 20 results of 63
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2 由 Helena Marzo‐Ortega, Joachim Sieper, Alan Kivitz, Ricardo Blanco, Martin Cohen, Evie-Maria Delicha, Susanne Rohrer, Hanno B. Richards
出版 2017Artigo -
10
Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol 由 Mark Quinn, Michael J. Green, Helena Marzo‐Ortega, Susanna Proudman, Zunaid Karim, Richard J. Wakefield, Philip G. Conaghan, Paul Emery
出版 2003Artigo -
11
Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study 由 Helena Marzo‐Ortega, Joachim Sieper, Alan Kivitz, Ricardo Blanco, Maxime C. Cohen, Roland Martinꝉ, Aimee Readie, H. Richards, Brian Porter
出版 2017Artigo -
12
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis 由 Dafna D. Gladman, Ana‐Maria Orbai, Uta Klitz, James Cheng‐Chung Wei, Gaia Gallo, Julie Birt, Suchitrita S. Rathmann, David Shrom, Helena Marzo‐Ortega
出版 2019Artigo -
13
Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis 由 Martín Rudwaleit, James T. Rosenbaum, Robert Landewé, Helena Marzo‐Ortega, Joachim Sieper, D. van der Heijde, O. Davies, Holger Bartz, Bengt Hoepken, T. Nurminen, Atul Deodhar
出版 2016Artigo -
14
-
15
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management... 由 Zoe Ash, C. Gaujoux-Viala, Laure Gossec, E. Hensor, Oliver FitzGerald, Kevin Winthrop, Désirée van der Heijde, Paul Emery, Josef S Smolen, Helena Marzo‐Ortega
出版 2011Revisão -
16
-
17
Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation 由 Mark Corbett, Marta Soares, Gurleen Jhuti, Stephen Rice, Eldon Spackman, E.G. Sideris, Thirimon Moe‐Byrne, Dave Fox, Helena Marzo‐Ortega, Lesley Kay, Nerys Woolacott, Stephen Palmer
出版 2016Revisão -
18
Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression 由 Richard Cuthbert, Abdulla Watad, Evangelos M. Fragkakis, Robert Dunsmuir, Peter Loughenbury, Almas Khan, Peter Millner, Adam Davison, Helena Marzo‐Ortega, Darren J. Newton, Charlie Bridgewood, Dennis McGonagle
出版 2019Artigo -
19
Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies 由 Atul Deodhar, C. Miceli-Richard, Xenofon Baraliakos, Helena Marzo‐Ortega, Dafna D. Gladman, Ricardo Blanco, Ayan Das Gupta, Ruvie Martin, Jorge Safi, Brian Porter, Abhijit Shete, James T. Rosenbaum
出版 2020Artigo -
20
<scp>Poly‐Refractory</scp> Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes 由 Paula David, Andrea Di Matteo, Or Hen, Shouvik Dass, Helena Marzo‐Ortega, Richard J. Wakefield, Leslie‐Anne Bissell, Jacqueline Nam, Kulveer Mankia, Paul Emery, Benazir Saleem, Dennis McGonagle
出版 2023Artigo
相關主題
Medicine
Internal medicine
Ankylosing spondylitis
Psoriatic arthritis
Physical therapy
Immunology
Arthritis
Pathology
Disease
Biology
Sacroiliitis
Axial spondyloarthritis
Psoriasis
Genetics
Gene
Spondylitis
Secukinumab
Surgery
Genotype
Dermatology
Intensive care medicine
Physics
Rheumatology
Single-nucleotide polymorphism
Alternative medicine
Computer science
Rheumatoid arthritis
Genotyping
Infliximab
Political science